New scan could spare patients unnecessary bone biopsies
NCT ID NCT05934994
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a detailed bone scan (SPECT-CT) can accurately tell if a single suspicious bone lesion is benign or malignant. Researchers will compare the scan results to biopsy findings in 68 adults. If the scan works well, it could help some people avoid the risks of an unnecessary biopsy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Bone scan (SPECT-CT)
- What this could lead to
- If successful, this scan could help doctors safely rule out cancer in suspicious bone spots without needing a biopsy.
- What could go wrong
- This is a small, early-stage study (68 people) testing a new way to use an existing scan. It may not prove accurate enough to replace biopsies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BONE LESION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHRU Nancy
RECRUITINGVandœuvre-lès-Nancy, 54511, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.